Closed · GH-BAA-2018-ADDENDUM03 · CFDA 98.001 · Discretionary

Innovations in Malaria Vaccine Development (IMV)

Federal grant opportunity posted by Agency for International Development, cataloged on Grants.gov.

up to $35.5M
Award range
Closed
Status
June 21, 2019
Close date
-
Expected awards

The verdict

Innovations in Malaria Vaccine Development (IMV) is a closed discretionary listing from Agency for International Development that offered Up to $35,500,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 753 other opportunities from Agency for International Development.

up to $35.5M
award range
Closed
application status
98.001
CFDA program
753
other opportunities from Agency for International Development

Archived opportunity record

Innovations in Malaria Vaccine Development is closed (last close June 21, 2019). Check the agency catalog for replacement NOFOs. Agency for International Development still indexes 753 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 21, 2019

Posted May 17 Closes Jun 21

Instrument

Other

Description

USAID is seeking to enhance our malaria vaccine investments through a collaborative design process. The goal of USAID’s Malaria Vaccine Development Program (MVDP) is to demonstrate the proof of concept of a vaccine to reduce morbidity and mortality due to malaria caused by infection with Plasmodium falciparum. Target malaria vaccine end characteristics will include at least 75% efficacy and evidence of affordability. USAID intends to support efforts towards vaccines that have the potential to directly protect recipients against disease caused by P. falciparum such as vaccines that target the pre-erythrocytic (sporozoite and liver stage) and erythrocytic stages of the life cycle. The purpose of this Addendum is to solicit Expressions of Interest (EOI) for novel and innovative approaches to malaria vaccine development that would encompass preclinical development through proof of principle clinical studies to motivate advanced development of a deployable, effective malaria vaccine.

Catch-all / unrestricted eligibility mark · GH-BAA-2018-ADDENDUM03

Grants.gov marks Innovations in Malaria Vaccine Development with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Other. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Agency for International Development book (340 peers, 45% of 754).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Christie Cooper Contract Specialist

More from Agency for International Development

Closed

Civil Society Strengthening Program (CSSP)

View →
Closed

The USAID BAA for Sustainable Development in Sub-Saharan Africa

View →
Closed

Pre-Solicitation Notice - Global Reconciliation Fund - People-to-People (P2P) Peacebuilding

View →
Closed

FY 2017 Conflict Mitigation and Reconciliation Programs and Activities (Global Reconciliation Fund)

View →
Closed

Pre-Solicitation Notice - Global Reconciliation Fund - People-to-People (P2P) Peacebuilding

View →

What to do next

Innovations in Malaria Vaccine Development is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 98.001 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants